Education
About Us
Working with TipRanks
Follow Us
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
Technical Sentiment
Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
BridgeBio Oncology Therapeutics’s (BBOT) Moving Averages Convergence Divergence (MACD) indicator is -0.17, suggesting BridgeBio Oncology Therapeutics is a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 20-Day exponential moving average is 9.83, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $9.9, making it a Buy.
BridgeBio Oncology Therapeutics’s (BBOT) 50-Day exponential moving average is 10.14, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $9.9, making it a Sell.
BridgeBio Oncology Therapeutics (BBOT) Pivot Points
Classic
8.87
9.29
9.68
10.10
10.49
10.91
11.30
Fibonacci
9.29
9.60
9.79
10.10
10.41
10.60
10.91
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
BridgeBio Oncology Therapeutics (BBOT) Moving Averages
MA5
9.67Buy
9.78Buy
MA10
9.52Buy
9.73Buy
MA20
9.84Buy
9.83Buy
MA50
10.26Sell
10.14Sell
MA100
10.55Sell
10.38Sell
MA200
10.62Sell
10.48Sell
BridgeBio Oncology Therapeutics’s (BBOT) 10-Day exponential moving average is 9.73, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $9.9, making it a Buy.
BridgeBio Oncology Therapeutics’s (BBOT) 100-Day exponential moving average is 10.38, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $9.9, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $9.9 and BridgeBio Oncology Therapeutics’s (BBOT) 50-day simple moving average is 10.26, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $9.9 and BridgeBio Oncology Therapeutics’s (BBOT) 100-day simple moving average is 10.55, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $9.9 and BridgeBio Oncology Therapeutics’s (BBOT) 200-day simple moving average is 10.62, creating a Sell signal.
BridgeBio Oncology Therapeutics (BBOT) Technical Indicators
RSI (14)
49.84
Neutral
STOCH (9,6)
71.60
Neutral
STOCHRSI (14)
32.63
Neutral
MACD (12,26)
-0.17
Sell
ADX (14)
14.52
Buy
Williams %R
-68.42
Buy
CCI (14)
-8.45
Neutral
ATR (14)
0.86
-
Ultimate Oscillator
47.81
Neutral
ROC
-7.04
Sell
BridgeBio Oncology Therapeutics’s (BBOT) Relative Strength Index (RSI) is 49.84, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Trend Strength Indicator (ADX) is 14.52, creating a Buy signal.
BridgeBio Oncology Therapeutics’s (BBOT) Commodity Channel Index (CCI) is -8.45, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Price Rate of Change (ROC) is -7.04, creating a Sell signal.
FAQ
Is BBOT a Buy, Hold, or Sell?
Based on BBOT’s technical indicators, BBOT is a Hold.
What is BBOT’s RSI (14)?
BBOT’s RSI (14) is 49.84, which suggests BBOT is a Neutral.
What is BBOT’s MACD?
BBOT’s MACD is -0.17, which suggests BBOT is a Sell.
What is BBOT’s 5-day moving average?
BBOT’s 5-day moving average is 9.67, which suggests BBOT is a Buy.
What is BBOT’s 20-day moving average?
BBOT 20-day moving average is 9.84, which suggests BBOT is a Buy.
What is BBOT’s 50-day moving average?
BBOT’s 50-day moving average is 10.26, which suggests BBOT is a Sell.
What is BBOT’s 200-day moving average?
BBOT’s 200-day moving average is 10.62, which suggests BBOT is a Sell.
What is BBOT’s Williams % R (14)?
BBOT’s Williams % R (14) is -68.42, which suggests BBOT is a Buy.
What is BBOT’s CCI (14)?
BBOT’s CCI (14) is -8.45, which suggests BBOT is a Neutral.